Ramank Madan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patients with EB experienced substantial reductions in affected skin area with continued use of the bark-derived topical agent oleogel-S10 in an open-label extension study.

Glasgow cityUnited kingdomNew yorkUnited statesRamank madanTracey cunninghamNorthwell healthEuropean medicines agencyDrug administrationAmryt pharmaceuticalsBritish association of dermatologistsBritish associationMedscape medical newsEpidermolysis bullosa disease activityScarring indexWound management